VERU

VERU INC.

Healthcare · Biotechnology

$110.14 sample

-0.06 (-0.05%) 1D

Market cap

$312.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-29

Alerts

8

Price$110.14 +20.71% 3M daily closessample

111.7390.52

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: Director
Oct 07INSInsider sell: 10% owner
Sep 29SECForm 144 filed
Sep 23INSInsider buy: Chief Financial Officer
Sep 14SEC8-K filed: material event
Sep 07INSInsider sell: 10% owner
Sep 02INSInsider buy: Chief Executive Officer
Aug 26INSInsider sell: Chief Financial Officer

Sign up to see the real VERU record →

Company facts

SEC EDGAR registration

Name: VERU INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -27sample, -100 to +100
Reporting currency: USD

Who is positioning in VERU

sample

Insiders: 7 insider transactions over 90 days, net selling, $569.2M
Congress: No member trades over 90 days
Institutions · 13F: 42 funds hold $2.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.3B +11.2% y/y

Q4 2024Q3 2026

Inventory$6.2B +13.0% y/y

Q4 2024Q3 2026

Accounts receivable$4.9B +15.4% y/y

Q4 2024Q3 2026

Total debt$12.3B +12.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $145.5B -6.1% 3M
Sample peer B: $115.9B +12.7% 3M
Sample peer C: $205.0B +2.7% 3M
Sample peer D: $85.2B +6.3% 3M
Sample peer E: $96.6B -4.6% 3M